PPT-Reversal of Betrixaban-Induced Anticoagulation in Healthy Volunteers by Andexanet Alfa

Author : lois-ondreau | Published Date : 2018-02-23

Disclosures Andexanet Designed to Reverse Activity of Factor Xa FXa Inhibitors Study Design Efficacy Endpoint Reduction in AntiFXa Activity Efficacy Endpoint Restoration

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Reversal of Betrixaban-Induced Anticoagu..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Reversal of Betrixaban-Induced Anticoagulation in Healthy Volunteers by Andexanet Alfa: Transcript

Disclosures Andexanet Designed to Reverse Activity of Factor Xa FXa Inhibitors Study Design Efficacy Endpoint Reduction in AntiFXa Activity Efficacy Endpoint Restoration of Thrombin Generation. Pegasys. ). Prepared by: David Spach, MD & H. Nina Kim, MD. Last Updated: February . 14, . 2014. Background and Dosing. Peginterferon alfa-2a (. Pegasys. ). Peginterferon alfa-2a (. Pegasys. ). Summary. Overview. . of. . PECS . projects. European Space . Agency Information . Day. 1. 1. th. January. , 2017. Point of Contact: . Ms. . Maite. Trujillo: maite.trujillo@esa.int. Mr. Laurent . Marchand. Using . SiPM. to readout Scintillating Fibers . What has been done for ALFA. The “Scintillating Fibers & . SiPM. ” status of the art. . ALFA. . SiPM. Collecting Information. Starting discussion. RBV . versus. Interferon alfa. -. 2a + RBV . ACTG 5071. Phase . 2. Treatment. . Naïve, Chronic HCV and HIV. Chung RT, . et. al. N . Engl. J Med. . 2004;351:451-9. . PEG alfa. -2a . + . RBV . versus. . . Feb 08/2014. Hanadi. . Alhozali,MBBS,ABIM,FRCPC. Assistant professor consultant internal medicine and Nephrology KAUH/Jeddah. Glomerular- based disease and Renal disease in pregnancy. Objectives. . PEG alfa-. 2a . versus. INF RBV . APRICOT STUDY. Phase 3. Treatment. . Naïve, Chronic HCV and HIV. Torriani. FJ, . et. al. N . Engl. J Med. . 2004;351:438-50. . PEG . . RBV . versus. . PEG . Announcements. Thank you attending the ACCP Cardiology PRN Journal Club. Please remain on mute during the . presentation. Thoughts, comments, and questions following the presentation are encouraged though!. Program Agenda. Crisis and Unmet Needs in Medically Ill Hospitalized Patients. Call to Action. World Thrombosis Day Facts. Absolute Risk of DVT in Hospitalized Patients. Lack of Prophylaxis in Medical Patients. Editorial April 2018 Alfa Laval reserves the right to change specifications without prior notification. Smooth - running ballast water treatment with Alfa Laval PureBallast 3 Dowa Line, USA, Case s Consultant HaematologistNewcastle Hospitals NHS TrustjohnhanleynuthnhsukBlood and Guts Reversal of anticoagulation in GI Bleeding Healthy situationHaemostatic seesaw in a happy balanceClinical Thrombo Geoffrey Barnes, MD, MSc. University of Michigan. @. GBarnesMD. May 14, 2020. Disclosures. Grants: Pfizer/Bristol-Myers Squibb, Blue Cross Blue Shield of Michigan, NHLBI, AHRQ. Consulting: Pfizer/Bristol-Myers Squibb, Janssen, Portola, AMAG Pharmaceuticals. Provided by ProCE, LLC and supported by an educational grant from . Alexion, AstraZeneca Rare Disease. About These Slides. Please feel free to use, update, and share some or all of these slides in your noncommercial presentations to colleagues or patients. . Interferon . alfa-2a. Phase 3. Treatment. . Naïve, Chronic HCV. Zeuzem. S, et al. N . Engl. J Med. 2000;343:1666-72.. Source: . Zeuzem. S, . et al. . N Engl J Med. 2000;343:1666-72.. Peginterferon alfa-2a versus Interferon alfa-. ID . : . DB00008 . Protein average . weight : . 60000.0000. . Half life : . Terminal half life is 80 hours (range 50 to 140 hours). . . Description. :. . Human interferon 2a, is a covalent conjugate of recombinant alfa-2a interferon with a single branched .

Download Document

Here is the link to download the presentation.
"Reversal of Betrixaban-Induced Anticoagulation in Healthy Volunteers by Andexanet Alfa"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.